With the advancement of the study of molecular biology, the research of the molecular targeted drugs such as EGFR inhibitor and VEGF inhibitor, become one of the hot spots.
随着分子生物学研究的进展，表皮生长因子受体抑制剂、血管内皮生长因子抑制剂等分子靶向药物的研究成为热点之一。
Also, in nononcologic therapeutic areas understanding the molecular biology of the disease increases; thus, the chances of developing specific targeted drugs increase.
另外，在非肿瘤治疗领域，随着从分子生物学角度更好的理解疾病，对于特定靶点药物的研究有所增加。
By focusing on these molecular and cellular changes, targeted cancer drugs go after the "target" in these cells, rather than just all cells.
它们观测分子和细胞的变化，找寻癌细胞靶点而不是所有细胞。
应用推荐